PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
226.29 - 230.79
161.38 - 242.52
38.50M / 42.21M (Avg.)
34.73 | 6.57
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-2.84%
Negative net income growth while JD stands at 10.51%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-0.04%
Negative yoy D&A while JD is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
40.18%
Deferred tax of 40.18% while JD is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-40.18%
Negative yoy SBC while JD is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
126.43%
Working capital change of 126.43% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
28.03%
AR growth of 28.03% while JD is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-100.21%
Negative yoy inventory while JD is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
114.69%
AP growth of 114.69% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-20.37%
Negative yoy usage while JD is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
22.72%
Some yoy increase while JD is negative at -301.39%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
83.14%
Some CFO growth while JD is negative at -173.37%. John Neff would note a short-term liquidity lead over the competitor.
-8.56%
Negative yoy CapEx while JD is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
81.90%
Acquisition growth of 81.90% while JD is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
98.36%
Purchases growth of 98.36% while JD is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-93.20%
We reduce yoy sales while JD is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
81.90%
Less 'other investing' outflow yoy vs. JD's 248.67%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
102.43%
Lower net investing outflow yoy vs. JD's 230.06%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
-29.18%
We cut debt repayment yoy while JD is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-35.42%
Negative yoy issuance while JD is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.